Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Warning Letter Recap, July 2021: Device Center Brings Hammer Down On Face Mask Vendors

Executive Summary

The US FDA says the 11 companies were selling masks without agency clearance, approval or authorization. A total of 13 device-related missives were released by the FDA in July.

You may also be interested in...



FDA Comes Down On Another Chinese N95 Manufacturer

The US agency says Shanghai Dasheng didn’t put a quality management system in place, and as a result has lost NIOSH approval for its N95 respirators. The agency told health care workers to stop using the masks.

Compliance Corner: Don’t Sign (Or Even Hear) That Affidavit!

Device makers presented with an affidavit by the US FDA during a facility inspection should walk away as quickly as possible, King & Spalding partner Jessica Ringel advises.

FDA Schedules 2 More Virtual Town Halls In October For COVID-19 Diagnostics

The US agency has announced two additional webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the coronavirus.

Topics

UsernamePublicRestriction

Register

MT144285

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel